Gregory I. Frost
2012
In 2012, Gregory I. Frost earned a total compensation of $2.3M as Former President and Chief Executive Officer at Halozyme Therapeutics, a 235% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $57,258 |
|---|---|
| Option Awards | $382,248 |
| Salary | $424,130 |
| Stock Awards | $1,423,274 |
| Other | $5,219 |
| Total | $2,292,129 |
Frost received $1.4M in stock awards, accounting for 62% of the total pay in 2012.
Frost also received $57.3K in non-equity incentive plan, $382.2K in option awards, $424.1K in salary and $5.2K in other compensation.
Rankings
In 2012, Gregory I. Frost's compensation ranked 3,106th out of 11,487 executives tracked by ExecPay. In other words, Frost earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,106 out of 11,487 | 73rd |
Division Manufacturing | 1,083 out of 4,253 | 75th |
Major group Chemicals And Allied Products | 243 out of 1,203 | 80th |
Industry group Drugs | 143 out of 925 | 85th |
Industry Biological Products, Except Diagnostic Substances | 25 out of 165 | 85th |
Source: SEC filing on April 3, 2015.
Frost's colleagues
We found five more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2012.
2012
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2012
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2012
James Shaffer
Halozyme Therapeutics
Former Vice President and Chief Commercial Officer
2012
Jean Liu
Halozyme Therapeutics
General Counsel
2012
David Ramsay
Halozyme Therapeutics